| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |